Health
Researchers report on novel SARS-CoV-2 Israeli strain with unique spike glycoprotein – News-Medical.Net
Researchers from Israel describe a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence…
In a recent medRxiv* preprint report, a research group from Israel described a novel SARS-CoV-2 strain with a non-synonymous mutation in its spike glycoprotein, designated as P681H; nevertheless, its emergence has not been associated with increased infections rate, facilitated spread or vaccine evasion.
The coronavirus disease 2019 (COVID-19) is still running rampant all over the world. As of March 2021, Israel found itself amidst the third wave of the infection. This resulted in tightening the…
-
Noosa News19 hours agoJessica Alba spotted filming spy thriller on the Gold Coast as cameras roll under iconic bridge
-
Noosa News16 hours agoDavid’s neighbour died alone. He now knows what comes next
-
Noosa News15 hours agoNoosa Council targeted in fraud
-
General18 hours agoACT family violence victims ‘waiting 3 or 4 days’ for help, inquiry hears